A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
Public ClinicalTrials.gov record NCT00449527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two-week, Randomised, Double-blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (≥ 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT® pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily
Study identification
- NCT ID
- NCT00449527
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Interventions
- Budesonide/formoterol pMDI Drug
- Budesonide HFA pMDI Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Not listed
- Completion
- Jul 31, 2007
- Last update posted
- Jan 23, 2011
2007
United States locations
- U.S. sites
- 44
- U.S. states
- 24
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tuscumbia | Alabama | — | — |
| Research Site | Fort Smith | Arkansas | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Riverside | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Jose | California | — | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | Valrico | Florida | — | — |
| Research Site | River Forest | Illinois | — | — |
| Research Site | Council Bluffs | Iowa | — | — |
| Research Site | Topeka | Kansas | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Bowling Green | Kentucky | — | — |
| Research Site | Florence | Kentucky | — | — |
| Research Site | Metairie | Louisiana | — | — |
| Research Site | City of Saint Peters | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Papillion | Nebraska | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Skillman | New Jersey | — | — |
| Research Site | Summit | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | New York | New York | — | — |
| Research Site | North Syracuse | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Greensboro | North Carolina | — | — |
| Research Site | Mooresville | North Carolina | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Tulsa | Oklahoma | — | — |
| Research Site | Collegeville | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Greenville | South Carolina | — | — |
| Research Site | Spartanburg | South Carolina | — | — |
| Research Site | Union | South Carolina | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | South Burlington | Vermont | — | — |
| Research Site | Bellingham | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
| Research Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00449527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00449527 live on ClinicalTrials.gov.